56 related articles for article (PubMed ID: 29168898)
1. Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population.
Tsakogiannis D; Moschonas GD; Bella E; Kyriakopoulou Z; Amoutzias GD; Dimitriou TG; Kottaridi C; Markoulatos P
J Med Virol; 2018 May; 90(5):965-971. PubMed ID: 29168898
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic variability in the exon 19 of the RB1 gene and its flanking intronic sequences in HPV16-associated precancerous lesions in the Greek population.
Tsakogiannis D; Moschonas GD; Daskou M; Stylianidou Z; Kyriakopoulou Z; Kottaridi C; Dimitriou TG; Gartzonika C; Markoulatos P
J Med Microbiol; 2018 Nov; 67(11):1638-1644. PubMed ID: 30303478
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population.
Thakur N; Hussain S; Nasare V; Das BC; Basir SF; Bharadwaj M
Mol Biol Rep; 2012 Jan; 39(1):407-14. PubMed ID: 21567202
[TBL] [Abstract][Full Text] [Related]
5. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
6. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
7. Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia.
Vargas-Torres SL; Portari EA; Silva AL; Klumb EM; da Rocha Guillobel HC; de Camargo MJ; Santos-Rebouças CB; Russomano FB; Macedo JM
Tumour Biol; 2016 Aug; 37(8):10469-78. PubMed ID: 26846214
[TBL] [Abstract][Full Text] [Related]
8. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
9. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
10. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Shete S; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):640-5. PubMed ID: 12101111
[TBL] [Abstract][Full Text] [Related]
11. Association of MicroRNA-10b Expression and P16 with Pathological Features in Various Stages of Cervical Precancerous Lesions.
Deng Y; Jiang H; Wu D
Cell Mol Biol (Noisy-le-grand); 2023 Jan; 69(1):109-113. PubMed ID: 37213147
[TBL] [Abstract][Full Text] [Related]
12. Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL.
Beca F; Pinheiro J; Rios E; Pontes P; Amendoeira I
Diagn Cytopathol; 2014 Nov; 42(11):919-23. PubMed ID: 24623593
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.
Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Chinchai T; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(1):341-6. PubMed ID: 23534750
[TBL] [Abstract][Full Text] [Related]
14. Genetic variant in CXCL12 gene raises susceptibility to HPV infection and squamous intraepithelial lesions development: a case-control study.
Okuyama NCM; Cezar-Dos-Santos F; Pereira ÉR; Trugilo KP; Cebinelli GCM; Sena MM; Pereira APL; Aranome AMF; Mangieri LFL; Ferreira RS; Watanabe MAE; de Oliveira KB
J Biomed Sci; 2018 Sep; 25(1):69. PubMed ID: 30227860
[TBL] [Abstract][Full Text] [Related]
15. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions.
Trugilo KP; Cebinelli GCM; Berti FCB; Okuyama NCM; Cezar-Dos-Santos F; Sena MM; Mangieri LFL; Watanabe MAE; de Oliveira KB
Med Microbiol Immunol; 2019 Feb; 208(1):49-58. PubMed ID: 30167873
[TBL] [Abstract][Full Text] [Related]
17. P16INK4a as an adjunct marker in liquid-based cervical cytology.
Sahebali S; Depuydt CE; Segers K; Moeneclaey LM; Vereecken AJ; Van Marck E; Bogers JJ
Int J Cancer; 2004 Mar; 108(6):871-6. PubMed ID: 14712490
[TBL] [Abstract][Full Text] [Related]
18. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
Bajpai D; Banerjee A; Pathak S; Thakur B; Jain SK; Singh N
Eur J Cancer Prev; 2016 May; 25(3):224-31. PubMed ID: 25812040
[TBL] [Abstract][Full Text] [Related]
20. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
